Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
Provided by
Dow Jones
By Denny Jacob
Abbott Laboratories' i-STAT TBI cartridge received clearance from the Food and Drug Administration to be used with whole blood, offering an additional tool for people with suspected concussions.
The healthcare-products manufacturer said the cartridge's ability to use whole blood will provide lab-quality results in 15 minutes.
Abbott said the clearance will enable testing in new healthcare settings beyond hospital emergency departments including urgent care clinics with a certificate to perform moderate complexity tests.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 01, 2024 09:34 ET (13:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters